{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:53:40Z","timestamp":1791543220963,"version":"4.3.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>\n                    Despite refinements in histologic criteria for the diagnosis of endometrioid precancers, many challenging cases are encountered in daily practice, creating diagnostic uncertainty and suboptimal patient management. Recently, an immunohistochemical 3-marker panel consisting of \u03b2-catenin, Pax2, and Pten was identified as a useful diagnostic adjunct. However, previous studies focused either on cancers or diagnostically unambiguous precancers, leaving questions about the applicability and utility of the panel in endometria with architectural features near or below the threshold of accepted histologic criteria for endometrioid precancers. Here, in a retrospective study of 90 patients, we evaluated the performance of the 3-marker panel. Notably, the panel detected a subset of disordered proliferative endometria (8\/44, 18%), nonatypical hyperplasias (19\/40, 48%), and cases with ambiguous features (3\/6, 50%) with aberrancy for \u22651 markers. Marker-aberrant cases were more likely to progress to endometrioid precancer or cancer (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0002). Patterns of marker aberrancy in the index and progressor cases from individual patients provided evidence for origin in a common precursor, and next-generation sequencing of the progressor cases rationalized marker aberrancy for \u03b2-catenin and Pten. The results unequivocally demonstrate that some lesions that do not approach current histologic thresholds are bona fide neoplastic precursors with clinically-relevant driver events that can be detected by the 3-marker panel. The findings provide further validation for the diagnostic utility of the panel in clinical practice and its application in difficult or ambiguous cases.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002034","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T07:03:19Z","timestamp":1679295799000},"page":"618-629","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["\u03b2-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions"],"prefix":"10.1097","volume":"47","author":[{"given":"Mitzi","family":"Aguilar","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhransu S.","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Obstetrics and Gynecology"},{"name":"Harold C. Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Grubman","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"SoRelle","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Once Upon a Time Human Genomics Center, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lucas","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Harold C. Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Castrillon","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Obstetrics and Gynecology"},{"name":"Harold C. Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semdp.2021.12.001","article-title":"Histopathologic diagnosis of endometrial precancers: updates and future directions","volume":"39","author":"Chen","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0b013e318159a2a0","article-title":"Diagnosing endometrial hyperplasia: why is it so difficult to agree?","volume":"32","author":"Allison","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004347-199701000-00006","article-title":"Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia","volume":"16","author":"Skov","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000478-199808000-00012","article-title":"Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma","volume":"22","author":"Kendall","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00004347-200010000-00002","article-title":"Histopathology of genetically defined endometrial precancers","volume":"19","author":"Mutter","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31802e4696","article-title":"Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia","volume":"26","author":"Mutter","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.semdp.2010.09.007","article-title":"Endometrial intraepithelial neoplasia","volume":"27","author":"Jarboe","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5858\/arpa.2012-0709-RA","article-title":"Endometrial intraepithelial neoplasia","volume":"138","author":"Owings","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/00313021003641758","article-title":"On the concept of objectivity in digital image analysis in pathology","volume":"42","author":"Tadrous","year":"2010","journal-title":"Pathology"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00313021003637624","article-title":"Objectivity in image analysis","volume":"42","author":"Leong","year":"2010","journal-title":"Pathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.2005.029702","article-title":"My approach to the interpretation of endometrial biopsies and curettings","volume":"59","author":"McCluggage","year":"2006","journal-title":"J Clin Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.2008.03104.x","article-title":"Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change","volume":"53","author":"Carlson","year":"2008","journal-title":"Histopathology"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41379-022-01124-5","article-title":"Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies","volume":"35","author":"Sahoo","year":"2022","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1309\/AJCP8OMLT7KDWLMF","article-title":"Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia","volume":"138","author":"Quick","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00125480-200303000-00001","article-title":"Biomarkers in diagnostic obstetric and gynecologic pathology: a review","volume":"10","author":"Nucci","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PGP.0000000000000549","article-title":"PI3K pathway effectors pAKT and FOXO1 as novel markers of endometrioid intraepithelial neoplasia","volume":"38","author":"Strickland","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PGP.0000000000000583","article-title":"Clinicopathologic and immunohistochemical correlates of CTNNB1 mutated endometrial endometrioid carcinoma","volume":"39","author":"Costigan","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/PGP.0000000000000557","article-title":"Mismatch repair protein expression in endometrioid intraepithelial neoplasia\/atypical hyperplasia: should we screen for Lynch syndrome in precancerous lesions?","volume":"38","author":"Lucas","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20250608","first-page":"20","article-title":"Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors","volume":"254","author":"Aguilar","year":"2021","journal-title":"J Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jpi.jpi_20_21","article-title":"SCHOOL: Software for Clinical Health in Oncology for Omics Laboratories","volume":"13","author":"Raulerson","year":"2022","journal-title":"J Pathol Inform"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"e2100113","DOI":"10.1200\/CCI.21.00113","article-title":"ANSWER: Annotation Software for Electronic Reporting","volume":"6","author":"Raulerson","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/PAS.0000000000001934","article-title":"Morules but not squamous differentiation are a reliable indicator of CTNNB1 (\u03b2-catenin) mutations in endometrial carcinoma and precancers","volume":"46","author":"Niu","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/PGP.0000000000000710","article-title":"POLE, MMR, and MSI testing in endometrial cancer: proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting","volume":"40","author":"Casey","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"25880","DOI":"10.1073\/pnas.1911310116","article-title":"Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition","volume":"116","author":"Cuevas","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0000000000000763","article-title":"Immunohistochemistry and next-generation sequencing are complementary tests in identifying PTEN abnormality in endometrial carcinoma biopsies","volume":"41","author":"Wang","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1111\/febs.15287","article-title":"Autism-associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line","volume":"287","author":"Wong","year":"2020","journal-title":"FEBS J"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.5566","article-title":"Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma","volume":"253","author":"Li","year":"2021","journal-title":"J Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.humpath.2017.07.003","article-title":"Clonal evolution in paired endometrial intraepithelial neoplasia\/atypical hyperplasia and endometrioid adenocarcinoma","volume":"67","author":"Russo","year":"2017","journal-title":"Hum Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat Genet"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fonc.2019.00123","article-title":"Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions in chinese patients by high-depth next generation sequencing","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2013.455","article-title":"Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas","volume":"109","author":"Akiyama-Abe","year":"2013","journal-title":"Br J Cancer"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"e138829","DOI":"10.1172\/jci.insight.138829","article-title":"A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1172\/JCI122095","article-title":"Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load","volume":"128","author":"Li","year":"2018","journal-title":"J Clin Invest"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/01.AOG.0000465189.50026.20","article-title":"The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001537","article-title":"Specific biomarker expression patterns in the diagnosis of residual and recurrent endometrial precancers after progestin treatment: a longitudinal study","volume":"44","author":"Chen","year":"2020","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T17:00:57Z","timestamp":1749402057000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002034","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}